Results 141 to 150 of about 24,009 (265)

Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris

Emerging Microbes and Infections
The study investigates the potential of lansoprazole, a proton pump inhibitor, to interfere with fungal respiration and enhance the antifungal activity of amphotericin B against multidrug-resistant Candida auris.
Meng Zhu, Hongyang Wang, Yongsheng Zhang, Fuzhen Pan   +3 more
doaj   +1 more source

PGI10 PHARMACY DISPENSING PATTERNS, COST AND HEALTHCARE UTILIZATION: A STUDY OF LANSOPRAZOLE

, 2002
ML Johnson, Rebecca J. Beyth
openalex   +1 more source

Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole

, 2013
Shu Sahara, Mitsushige Sugimoto, Takahiro Uotani, H. Ichikawa, Mihoko Yamade, Moriya Iwaizumi, Takahiro Yamada, Satoshi Osawa, Ken Sugimoto, Kazuo Umemura, Hiroaki Miyajima, Takahisa Furuta   +11 more
openalex   +2 more sources

Lansoprazole‐based sequential and concomitant therapy for the first‐line Helicobacter pylori eradication [PDF]

, 2012
Yao-Kang Huang, Meng‐Chieh WU, Sophie SW WANG, Chao‐Hung Kuo, Yi‐Chern LEE, Ling-li Chang, Tsung‐Hsi WANG, Yen‐Hsu Chen, Wenming Wang, Deng-Chyang Wu, Fu‐Chen Kuo   +10 more
openalex   +1 more source

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole

Gut and Liver, 2010
Background/Aims: The CYP2C19 polymorphism plays an important role in the metabolism of various proton-pump inhibitors. Several trials have produced conflicting data on eradication rates of Helicobacter pylori (H. pylori) among CYP2C19 genotypes.
doaj   +1 more source

Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin [PDF]

, 2003
Keitaro Matsuo, Nobuyuki Hamajima, Yuzuru Ikehara, Takeshi Suzuki, Taro Nakamura, Akihiro Matsuura, Keisuke Tajima, Suketami Tominaga   +7 more
openalex   +1 more source

Inhibition of Gastric H⁺,K⁺-ATPase Activity <i>in Vitro</i> by Dissolution Media of Original Brand-Name and Generic Tablets of Lansoprazole, a Proton Pump Inhibitor

, 2018
Siriporn Phutthatiraphap, Yoshihiro Hayashi, Takuto Fujii, Atsushi Kosugi, Kotaro Okada, Tetsuo Kadozaki, Toru Ishise, Hideki Sakai, Yoshinori Onuki   +8 more
openalex   +2 more sources

Adolescent patients with gastroesophageal reflux disease (GERD): Results from a randomized trial of lansoprazole

, 2000
Sandeep K. Gupta, Vasundhara Tolia, Melvin B. Heyman, Robert E. Kane, Yi‐Lin Chiu, Wei‐Jian Pan, Bidan Huang, Roberta Keith, Eric Hassall   +8 more
openalex   +1 more source

The effect of lansoprazole administration during pregnancy on the placenta

, 2016
Ali Louei Monfared, Morteza Shamsi
openalex   +1 more source

Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects [PDF]

, 2003
James W. Freston, Yen‐Ling Chiu, Darcy J. Mulford, Elizabeth D. Ballard   +3 more
openalex   +1 more source